The Scientist


Most Recent

image: Formaldehyde Fears

Formaldehyde Fears

By | October 1, 2015

Data on the links between ALS and the chemical have been contradictory, but the latest study suggests undertakers are at risk.

1 Comment

image: Undertaker's Bane

Undertaker's Bane

By | October 1, 2015

Harvard Professor Marc Weisskopf discusses the potential link between formaldehyde and ALS.

1 Comment

image: ALS Drug Access Debated

ALS Drug Access Debated

By | April 7, 2015

Biotech company Genervon has requested accelerated approval for its experimental ALS drug after a small but promising Phase 2 trial. Patients advocate for its acceptance, while researchers urge caution.


image: Beneficial Stats

Beneficial Stats

By | March 1, 2015

Statisticians who normally crunch numbers to forecast trends in the food-service industry turn their attention to bettering treatment of ALS.


The ALS Association has raised more than $100 million in donations through a charity campaign that went viral. How should that money be spent?

1 Comment

image: Ice Bucket Challenge Irony

Ice Bucket Challenge Irony

By | August 25, 2014

Several US legislators who voted in favor of a bill that cut federal funding for ALS research have taken the chilly plunge for charity.


image: Non-coding Repeats Cause Peptide Clumps

Non-coding Repeats Cause Peptide Clumps

By | February 7, 2013

Protein aggregates in the brains of some people with dementia or motor neuron disease have a surprising origin.


image: Medical Mavericks

Medical Mavericks

By | July 1, 2012

ALS patients take their fate into their own hands, self-administering an unapproved chemical and collating their results online.



Popular Now

  1. Antidepressant Exerts Epigenetic Changes
  2. The Unregulation of Biotech Crops
  3. Image of the Day: Mother’s Love
  4. Remote Mind Control
Life Technologies